Thus, it is reasonable to speculate that TRAF2 in osteotropic breast cancer cells orchestrates the expression of a set of tumour-derived factors that function cooperatively to alter the balance between osteoblasts and osteoclasts. This evidence concerns the gene TRAF2 and breast cancer.